TABLE 1.
Baseline patient characteristics
| Parameters | ITI population, all patients, n (%) |
|---|---|
| Demographic | |
| Sex, male | 20 (100) |
| Age, years, median (range) | 6.2 (3–12) |
| Height, cm, median (range) | 114 (95–155) |
| Body weight, Kg/m2 | |
| ≤24 | 14 (70) |
| > 24 ‐ ≤28 | 5 (25) |
| > 28 | 1 (5) |
| Race, Arab | 20 (100) |
| Clinical data | |
| HA severity, FVIII < 1 IU/dl | 20 (100) |
| Blood group | |
| A | 4 (20) |
| B | 8 (40) |
| AB | 2 (10) |
| O | 6 (30) |
| Surgery | 1 (5) |
| Concomitant disease | |
| Cardiovascular disease | 0 (0) |
| Asthma | 2 (10) |
| Inhibitor antecedents | 2 (10) |
| Serology | |
| HIV+/HCV+ | 0 (0) |
| HCV+ | 2 (10) |
Abbreviations: ABR, annual bleeding rate; FVIII, Factor VIII; HA, haemophilia A; HCV, hepatitis C virus; HIV, Human immunodeficiency virus; ITI, immune tolerance induction.